Indicators
Indicators
Value
Direction
MACD(12,26,9)
1.035
Buy
RSI(14)
53.150
Neutral
STOCH(KDJ)(9,3,3)
74.647
Neutral
ATR(14)
4.319
High Vlolatility
CCI(14)
47.787
Neutral
Williams %R
35.089
Buy
TRIX(12,20)
0.061
Sell
StochRSI(14)
0.000
Sell
Balchem Corp
BCPC156.300USD
-2.420-1.52%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
5.06BMarket Cap
33.90P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Balchem Corp
Currency: USD Updated: 2025-12-19Key Insights
Balchem Corp's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 12/70 in the Chemicals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 191.00.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Balchem Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
3
analysts
Buy
Current Rating
191.000
Target Price
+29.61%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Balchem Corp Highlights
StrengthsRisks
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 953.68M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 22.16%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 22.16%.
Undervalued
The company’s latest PB is 3.90, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 30.08M shares, increasing 0.06% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 188.00 shares of this stock.
Financial Health
Currency: USD Updated: 2025-12-19The current financial score of Balchem Corp is 9.12, ranking 5/70 in the Chemicals industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 267.56M, representing a year-over-year increase of 11.51%, while its net profit experienced a year-over-year increase of 19.07%.
Score
Financials
9.00
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
8.53
Operational Efficiency
9.60
Growth Potential
8.97
Shareholder Returns
9.48
Balchem Corp's Company Valuation
Currency: USD Updated: 2025-12-19The current valuation score of Balchem Corp is 3.54, ranking 70/70 in the Chemicals industry. Its current P/E ratio is 33.90, which is 47.69% below the recent high of 50.07 and 10.24% above the recent low of 30.43.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 12/70
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-19The current earnings forecast score of Balchem Corp is 8.00, ranking 10/70 in the Chemicals industry. The average price target for Balchem Corp is 191.00, with a high of 220.00 and a low of 162.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
191.000
Target Price
+29.61%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
62
Total
5
Median
6
Average
Company name
Ratings
Analysts
Balchem Corp
BCPC
3
Apple Inc
AAPL
50
Ge Vernova Inc
GEV
34
Tapestry Inc
TPR
21
FMC Corp
FMC
21
Verisk Analytics Inc
VRSK
20
1
2
3
...
13
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-19The current price momentum score of Balchem Corp is 8.59, ranking 27/70 in the Chemicals industry. Currently, the stock price is trading between the resistance level at 162.63 and the support level at 148.58, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
158.093
Sell
MA10
154.922
Buy
MA20
154.774
Buy
MA50
153.400
Buy
MA100
154.655
Buy
MA200
158.214
Sell
Institutional Confidence
Currency: USD Updated: 2025-12-19The current institutional shareholding score of Balchem Corp is 10.00, ranking 1/70 in the Chemicals industry. The latest institutional shareholding proportion is 92.73%, representing a quarter-over-quarter increase of 0.07%. The largest institutional shareholder is The Vanguard, holding a total of 3.89M shares, representing 12.00% of shares outstanding, with 1.85% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
Conestoga Capital Advisors, LLC
State Street Investment Management (US)
Geode Capital Management, L.L.C.
Geneva Capital Management LLC
Dimensional Fund Advisors, L.P.
Norges Bank Investment Management (NBIM)
JP Morgan Asset Management
1
2
Risk Assessment
Currency: USD Updated: 2025-12-19The current risk assessment score of Balchem Corp is 9.10, ranking 5/70 in the Chemicals industry. The company's beta value is 0.96. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.96
VaR
+2.35%
240-Day Maximum Drawdown
+20.36%
240-Day Volatility
+27.85%
Return
Best Daily Return
60 days
+4.10%
120 days
+4.10%
5 years
+6.28%
Worst Daily Return
60 days
-2.24%
120 days
-3.49%
5 years
-6.95%
Sharpe Ratio
60 days
+0.61
120 days
-0.08
5 years
+0.30
Risk Assessment
Maximum Drawdown
240 days
+20.36%
3 years
+23.50%
5 years
+34.14%
Return-to-Drawdown Ratio
240 days
-0.03
3 years
+0.14
5 years
+0.11
Skewness
240 days
+0.58
3 years
+0.33
5 years
+0.12
Volatility
Realised Volatility
240 days
+27.85%
5 years
+26.73%
Standardised True Range
240 days
+2.32%
5 years
+2.12%
Downside Risk-Adjusted Return
120 days
-15.32%
240 days
-15.32%
Maximum Daily Upside Volatility
60 days
+19.31%
Maximum Daily Downside Volatility
60 days
+12.60%
Liquidity
Average Turnover Rate
60 days
+0.52%
120 days
+0.55%
5 years
--
Turnover Deviation
20 days
+24.31%
60 days
+31.03%
120 days
+37.07%
Peer Comparison
Chemicals
Balchem Corp
BCPC
8.04 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Linde PLC
LIN
8.52 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ecovyst Inc
ECVT
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
CF Industries Holdings Inc
CF
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cabot Corp
CBT
8.30 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Innospec Inc
IOSP
8.26 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of Balchem Corp?
The TradingKey Stock Score provides a comprehensive assessment of Balchem Corp based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Balchem Corp’s performance and outlook.
How do we generate the financial health score of Balchem Corp?
To generate the financial health score of Balchem Corp, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects Balchem Corp's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Balchem Corp.
How do we generate the company valuation score of Balchem Corp?
To generate the company valuation score of Balchem Corp, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Balchem Corp’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Balchem Corp’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Balchem Corp.
How do we generate the earnings forecast score of Balchem Corp?
To calculate the earnings forecast score of Balchem Corp, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Balchem Corp’s future.
How do we generate the price momentum score of Balchem Corp?
When generating the price momentum score for Balchem Corp, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of Balchem Corp’s prices. A higher score indicates a more stable short-term price trend for Balchem Corp.
How do we generate the institutional confidence score of Balchem Corp?
To generate the institutional confidence score of Balchem Corp, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Balchem Corp’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Balchem Corp.
How do we generate the risk management score of Balchem Corp?
To assess the risk management score of Balchem Corp, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of Balchem Corp’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Balchem Corp.
